Differential effects of human neutrophil peptide-1 on growth factor and interleukin-8 production by human lung fibroblasts and epithelial cells

Experimental Lung Research

Volumn 36, Issue 7, 2010, Pages 411-419

  Amenomori, Misato ^a   Mukae, Hiroshi ^a,b   Ishimatsu, Yuji ^a   Sakamoto, Noriho ^a   Kakugawa, Tomoyuki ^a   Hara, Atsuko ^a   Hara, Shintaro ^a   Fujita, Hanako ^a   Ishimoto, Hiroshi ^a   Hayashi, Tomayoshi ^c   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Epithelial cells; Fibroblasts; Human neutrophil peptide 1; KEYWORDS defensins

Indexed keywords

ALPHA DEFENSIN; INTERLEUKIN 8; NEUTROPHIL PEPTIDE 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALPHA-DEFENSINS; BRONCHIOLITIS; CELLS, CULTURED; CYSTIC FIBROSIS; EPITHELIAL CELLS; FIBROBLASTS; HAEMOPHILUS INFECTIONS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTERLEUKIN-8; LUNG; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77955886069     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902141003714049     Document Type: Article

References (45)

1. Sibille Y, Marchandise FX: Pulmonary immune cells in health and disease: polymorphonuclear neutrophils. Eur Respir J. 1993;6:1529-1543.
2. Van Wetering S, Mannesse-Lazeroms SP, Dijkman JH, Hiemstra PS: Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J Leukoc Biol. 1997;62:217-226.
3. Ashitani J, Mukae H, Nakazato M, Kohno S: Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis. Eur Respir J. 1998;11:104-111.
4. Mukae H, Iiboshi H, Nakazato M, Hiratsuka T, Tokojima M, Abe K, Ashitani J, Kadota J, Matsukura S, Kohno S: Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis. Thorax. 2002;57:623-628.
5. Ashitani J, Mukae H, Hiratsuka T, Nakazato M, Kumamoto K, Matsukura S: Plasma and BAL fluid concentrations of antimicrobial peptides in patients with Mycobacterium aviumintracellulare infection. Chest. 2001;119:1131-1137.
6. Moraes TJ, Chow CW, Downey GP: Proteases and lung injury. Crit Care Med. 2003;31:S189-S194.
7. Chua F, Laurent GJ: Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc. 2006;3:424-427.
8. Aarbiou J, Rabe KF, Hiemstra PS: Role of defensins in inflammatory lung disease. Ann Med. 2002;34:96-101.
9. Khine AA, Del Sorbo L, Vaschetto R, Voglis S, Tullis E, Slutsky AS, Downey GP, Zhang H: Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway. Blood. 2006;107:2936-2942.
10. VanWetering S,Mannesse-Lazeroms SP, Van Sterkenburg MA, Daha MR, Dijkman JH, Hiemstra PS: Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol. 1997;272:L888-L896.
11. Sakamoto N, Mukae H, Fujii T, Ishii H, Yoshioka S, Kakugawa T, Sugiyama K, Mizuta Y, Kadota J, Nakazato M, Kohno S: Differential effects of alpha- and beta-defensin on cytokine production by cultured human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2005;288:L508-L513.
12. Liu CY, Lin HC, Yu CT, Lin SM, Lee KY, Chen HC, Chou CL, Huang CD, Chou PC, Liu WT, Wang CH, Kuo HP: The concentration-dependent chemokine release and pro-apoptotic effects of neutrophil-derived alpha-defensin-1 on human bronchial and alveolar epithelial cells. Life Sci. 2007;80:749-758.
13. Ishimoto H, Mukae H, Sakamoto N, Amenomori M, Kitazaki T, Imamura Y, Fujita H, Ishii H, Nakayama S, Yanagihara K, Kohno S: Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin. J Antimicrob Chemother. 2009;63:109-114.
14. Yoshioka S, Mukae H, Ishii H, Kakugawa T, Ishimoto H, Sakamoto N, Fujii T, Urata Y, Kondo T, Kubota H, Nagata K, Kohno S: Alpha-defensin enhances expression of HSP47 and collagen-1 in human lung fibroblasts. Life Sci. 2007;80:1839-1845.
15. Vaschetto R, Grinstein J, Del Sorbo L, Khine AA, Voglis S, Tullis E, Slutsky AS, Zhang H: Role of human neutrophil peptides in the initial interaction between lung epithelial cells and CD4+ lymphocytes. J Leukoc Biol. 2007;81:1022-1031.
16. Voglis S, Quinn K, Tullis E, Liu M, Henriques M, Zubrinich C, Penuelas O, Chan H, Silverman F, Cherepanov V, Orzech N, Khine AA, Cantin A, Slutsky AS, Downey GP, Zhang H: Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs. Am J Respir Crit Care Med. 2009;180:159-166.
17. Shute J, Marshall L, Bodey K, Bush A: Growth factors in cystic fibrosis-when more is not enough. Paediatr Respir Rev. 2003;4:120-127.
18. Kelly M, Kolb M, Bonniaud P, Gauldie J: Re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Des. 2003;9:39-49.
19. Ask K, Martin GE, Kolb M, Gauldie J: Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls. Proc Am Thorac Soc. 2006;3:389-393.
20. McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE: Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med. 2000;161:1877-1880.
21. Soong LB, Ganz T, Ellison A, Caughey GH: Purification and characterization of defensins from cystic fibrosis sputum. Inflamm Res. 1997;46:98-102.
22. Kunkel SL, Standiford T, Kasahara K, Strieter RM: Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res. 1991;17:17-23.
23. Moorman JP, Fitzgerald SM, Prayther DC, Lee SA, Chi DS, Krishnaswamy G: Induction of p38- and gC1qR-dependent IL- 8 expression in pulmonary fibroblasts by soluble hepatitis C core protein. Respir Res. 2005;6:105.
24. Kadota J, Sakito O, Kohno S, Sawa H, Mukae H, Oda H, Kawakami K, Fukushima K, Hiratani K, Hara K: A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis. 1993;147:153-159. (Pubitemid 23025932)
25. Xaubet A, Agusti C, Luburich P, Barbera JA, Carrion M, Ayuso MC, Roca J, Rodriguez-Roisin R: Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis. Respir Med. 1998;92:338-344.
26. Poletti V, Casoni G, Chilosi M, ZompatoriM:Diffuse panbronchiolitis. Eur Respir J. 2006;28:862-871.
27. Lasky JA, Brody AR: Interstitial fibrosis and growth factors. Environ Health Perspect. 2000;108(Suppl 4):751-762.
28. Khalil N, OConnor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH: Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis.AmJ Respir Cell Mol Biol. 1991;5:155-162.
29. Giri SN, Hyde DM, Hollinger MA: Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax. 1993;48:959-966.
30. Nakayama S, Mukae H, Sakamoto N, Kakugawa T, Yoshioka S, Soda H, Oku H, Urata Y, Kondo T, Kubota H, Nagata K, Kohno S: Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts. Life Sci. 2008;82:210-217.
31. Kelley TJ, Elmer HL, Corey DA: Reduced Smad3 protein expression and altered transforming growth factor-beta1- mediated signaling in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol. 2001;25:732-738.
32. Jagels MA, Hugli TE: Mixed effects of TGF-beta on human airway epithelial-cell chemokine responses. Immunopharmacology. 2000;48:17-26.
33. Veikkola T, Alitalo K: VEGFs, receptors and angiogenesis. Semin Cancer Biol. 1999;9:211-220.
34. Simler NR, Brenchley PE, Horrocks AW, Greaves SM, Hasleton PS, Egan JJ: Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax. 2004;59:581-585.
35. McKeown S, Richter AG, OKane C, McAuley DF, Thickett DR: MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur Respir J. 2009;33:77-84.
36. Krenn K, Klepetko W, Taghavi S, Paulus P, Aharinejad S: Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation. Eur J Cardiothorac Surg. 2007;32:35-41.
37. Klagsbrun M, DAmore PA: Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 1996;7:259-270.
38. Economopoulou M, Bdeir K, Cines DB, Fogt F, Bdeir Y, Lubkowski J, Lu W, Preissner KT, Hammes HP, Chavakis T: Inhibition of pathologic retinal neovascularization by alphadefensins. Blood. 2005;106:3831-3838.
39. Chen CM, Wang LF, Chou HC, Lang YD, Lai YP: Upregulation of connective tissue growth factor in hyperoxiainduced lung fibrosis. Pediatr Res. 2007;62:128-133.
40. Okada H, Kikuta T, Kobayashi T, Inoue T, Kanno Y, Takigawa M, Sugaya T, Kopp JB, SuzukiH: Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol. 2005;16:133-143.
41. Grotendorst GR: Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 1997;8:171-179.
42. Ricupero DA, Rishikof DC, Kuang PP, Poliks CF, Goldstein RH: Regulation of connective tissue growth factor expression by prostaglandin E(2). Am J Physiol. 1999;277:L1165-L1171.
43. Wunderlich K, Senn BC, Todesco L, Flammer J, Meyer P: Regulation of connective tissue growth factor gene expression in retinal vascular endothelial cells by angiogenic growth factors. Graefes Arch Clin Exp Ophthalmol. 2000;238:910-915.
44. Pan LH, Yamauchi K, Uzuki M, Nakanishi T, Takigawa M, Inoue H, Sawai T: Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur Respir J. 2001;17:1220-1227.
45. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol. 1996;107:404-411.